During the past decade, Abdullah Beyoğlu conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Abdullah Beyoğlu" are "Diabetes Mellitus" (1 trials), "Diabetic Retinopathy" (1 trials), "Eye Manifestations" (1 trials), "Hormones" (1 trials) and "Tobacco Chewing Toxicity" (1 trials). Many other conditions were trialed in "Abdullah Beyoğlu" in a lesser frequency.

Most popular intervention types in "Abdullah Beyoğlu" are "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "The effect of GPER-1 on the formation of diabetic retinopathy" (1 trials) and "optical biometry measurement" (1 trials). Other intervention names were less common.

The vast majority of trials in "Abdullah Beyoğlu" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Abdullah Beyoğlu". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Abdullah Beyoğlu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Abdullah Beyoğlu, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".